Clinical trial
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? A Clinical, Prospective, Randomized, Blinded Examination of Patients Suffering From Hematological Malignancies Treated With Intensive Chemotherapy and/or Radiotherapy.
NCT00892502 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? A Clinical, Prospective, Randomized, Blinded Examination of Patients Suffering From Hematological Malignancies Treated With Intensive Chemotherapy and/or Radiotherapy.
- Lead sponsor
- Copenhagen University Hospital at Herlev
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 31, 2009
- Completion date
- February 28, 2013
- Enrollment
- 50 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood diseases, hematological diseases, hematological malignancies, leukemia, malignant lymphoma, multiple myeloma